Recent advances in the pharmacological treatment of glaucoma.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002186:Cannabinoids / Q000627:therapeutic use; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D004234:Diuretics, Osmotic / Q000627:therapeutic use; D005901:Glaucoma / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D006801:Humans; D010277:Parasympathomimetics / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002186:Cannabinoids; D002257:Carbonic Anhydrase Inhibitors; D004234:Diuretics, Osmotic; D010277:Parasympathomimetics; D013566:Sympathomimetics